Výsledky vyhledávání - "Vishal Saundankar"

Akademický článek

Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study

Autor: Bonnie B. Dean, Vishal Saundankar, Dana Stafkey-Mailey, Rebekah H. Anguiano, Andrew C. Nelsen, Kathryn Gordon, Peter Classi

Publikováno v: Drugs - Real World Outcomes, Vol 7, Iss 3, Pp 229-239 (2020)

Abstract Background Given the improved convenience of oral prostacyclins, there is a shift toward their use in treating pulmonary arterial hypertension (PAH). Objectives Our objective was to compare patient characteristics, medication adherence, heal

Externí odkaz: https://doaj.org/article/da51c1c33cd34acc9a98dc6360df4665

Zobrazit plný text záznamu

Akademický článek

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer’s disease in an administrative claims database

Autor: Radhika Nair, Virginia S. Haynes, Mir Siadaty, Nick C. Patel, Adam S. Fleisher, Derek Van Amerongen, Michael M. Witte, AnnCatherine M. Downing, Leslie Ann Hazel Fernandez, Vishal Saundankar, Daniel E. Ball

Publikováno v: BMC Geriatrics, Vol 18, Iss 1, Pp 1-12 (2018)

Abstract Background The objective of this study was to examine patient characteristics and health care resource utilization (HCRU) in the 36 months prior to a confirmatory diagnosis of Alzheimer’s disease (AD) compared to a matched cohort without d

Externí odkaz: https://doaj.org/article/60f1b9bd8617482eb46d8c3329b74bf4

Zobrazit plný text záznamu

Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents

Autor: Deepa Lalla, Reshma Mahtani, Vishal Saundankar, Augustina Ogbonnaya, Kelly E McCann, Joanne Willey, Anna D. Coutinho, Nina Oestreicher

Publikováno v: Cancer Research. 81:PS9-54

Background: Human Epidermal Growth Factor Receptor 2 positive (HER2+) breast cancer (BC) represents approximately 15% of early stage BC cases and is associated with a more aggressive clinical phenotype and poor prognosis with respect to most BC. Over

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::91c0ac7d35c6dcb096b2dbd98ebb1019
https://doi.org/10.1158/1538-7445.sabcs20-ps9-54

Zobrazit plný text záznamu

Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study

Autor: Peter Classi, Kathryn Gordon, Rebekah H. Anguiano, Andrew Nelsen, Vishal Saundankar, Dana Stafkey-Mailey, Bonnie B. Dean

Publikováno v: Drugs-Real World Outcomes, Vol 7, Iss 3, Pp 229-239 (2020)
Drugs-Real World Outcomes

Background Given the improved convenience of oral prostacyclins, there is a shift toward their use in treating pulmonary arterial hypertension (PAH). Objectives Our objective was to compare patient characteristics, medication adherence, healthcare re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7716aa081da462c0123c202bf4db0ff8
https://doi.org/10.1007/s40801-020-00183-x

Zobrazit plný text záznamu

Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Autor: Deepa Lalla, Anna D. Coutinho, Vishal Saundankar, Reshma Mahtani, Kelly E McCann, Augustina Ogbonnaya, Nina Oestreicher, Joanne Willey

Publikováno v: Clinical breast cancer. 22(4)

Introduction : HER2-positive metastatic breast cancer (mBC) is an incurable disease associated with years of chronic therapy and excess cost. HER2-targeted therapies have shown survival benefit for early-stage and mBC; however, the economic impact of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc7a3f17cbe98d300a348f87a684aa7b
https://pubmed.ncbi.nlm.nih.gov/35067467

Zobrazit plný text záznamu

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms

Autor: Scott Manaker, Peter Classi, Rebekah H. Anguiano, Anna R. Hemnes, Corey E. Ventetuolo, Kathryn Gordon, Andrew Nelsen, Bonnie B. Dean, Vishal Saundankar, Stephen C. Mathai

Publikováno v: Annals of the American Thoracic Society

Retrospective administrative claims database studies provide real-world evidence about treatment patterns, healthcare resource use, and costs for patients and are increasingly used to inform policy-making, drug formulary, and regulatory decisions. Ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbd4503045b75205f58dad1e6804d4f
http://europepmc.org/articles/PMC6600840

Zobrazit plný text záznamu

Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers

Autor: Lucio Gordan, Vishal Saundankar, Michael Eaddy, Susan Weidner, Marlo Blazer, Denise Kazzaz

Publikováno v: Journal of Oncology Practice. 14:e729-e738

Purpose: Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db9a4146c42df0a32206a8f3733d1f6
https://doi.org/10.1200/jop.17.00040

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání